Amid high demand for mental health care, some individuals have turned to AI chatbots for emotional support — but a new study ...

There is no doubt artificial intelligence (AI) has the potential to improve access to mental health care. “One could imagine ...

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

The triplet therapy was effective only in patients with nonmutated PIK3CA and ESR1 genes, achieving a median PFS of 9.1 ...

A method to address discrepancies between predicted biological age and actual chronological age has been validated as a biomarker in predicting OS.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the expansion of its Guardant ...

Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...

As PET scans fall short, blood-based circulating tumor DNA testing shows promise in monitoring large B-cell lymphoma ...

U.S. guidelines started discouraging prophylactic low-dose aspirin for adults over 70 in 2019. The U.S. Preventive Services ...

Near-term – Closing and funding of the Quazar Investment of $50 million.

FDA Commissioner Marty Makary announced FDA’s plans for a new drug approval pathway named the Plausible Mechanism Pathway ...